ADIA Adia Med, Inc.
Fundamentals / CIK 0001160420 / USDAdia Med, Inc. reported $1.20M in revenue and a net loss of $498K for the trailing twelve months ended September 30, 2026 (up 36.8% year over year), with a 35.3% gross margin and a -38.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ADIA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$1.20M +36.8% YoY
-
Operating Income TTM-$455K -38.0% margin
-
Net Income TTM-$498K -41.5% net margin
-
Diluted EPS TTM-$0.01 Split-adjusted
-
Free Cash Flow TTM-$326K -27.2% FCF margin
-
Cash & ST Investments Sep 30, 2026$1.14M Total debt: $139K
Annual revenue and net income
2 fiscal years (2024 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 |
|---|---|---|
| Revenue | $701K | $6.4K |
| Cost of Revenue | $509K | $4.2K |
| Gross Profit | $192K | $2.2K |
| Research & Development | $29K | $0 |
| Total Operating Expenses | $558K | $177K |
| Operating Income | -$366K | -$175K |
| EBITDA | -$362K | -$174K |
| Interest Income | $625 | $0 |
| Interest Expense | $32K | $6.3K |
| Income Before Tax | -$395K | -$181K |
| Income Tax Expense | $0 | $0 |
| Net Income | -$395K | -$181K |
| Basic EPS | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 |
| Basic Shares Outstanding | 93.6M | 91.7M |
| Diluted Shares Outstanding | 93.6M | 91.7M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Revenue | $454K | $389K | $176K | $179K | $332K | $118K | $72K |
| Cost of Revenue | $233K | $203K | $109K | $230K | $129K | $92K | $58K |
| Gross Profit | $221K | $186K | $68K | -$52K | $203K | $26K | $14K |
| Research & Development | $4.4K | $0 | -- | -- | $6.2K | $25K | -- |
| Total Operating Expenses | $260K | $231K | $219K | $167K | $124K | $143K | $125K |
| Operating Income | -$39K | -$45K | -$152K | -$219K | $79K | -$117K | -$111K |
| EBITDA | -$38K | -$44K | -$151K | -$218K | $80K | -$115K | -$110K |
| Interest Income | -- | $375 | $375 | -- | -- | $0 | $0 |
| Interest Expense | $14K | -$12K | $11K | $9.4K | $9.1K | $7.4K | $5.7K |
| Income Before Tax | -$53K | -$56K | -$163K | -$226K | $70K | -$124K | -$116K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$53K | -$56K | -$163K | -$226K | $70K | -$124K | -$116K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 94.4M | 94.4M | 94.4M | -- | 91.2M | 89.6M | 95.9M |
| Diluted Shares Outstanding | 94.4M | 161.4M | 94.4M | -- | 158.2M | 89.6M | 95.9M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $79K | $6.3K |
| Cash & Short-Term Investments | $79K | $6.3K |
| Accounts Receivable, Net | $33K | $0 |
| Inventory | $25K | $207K |
| Total Current Assets | $162K | $258K |
| Property, Plant & Equipment, Net | $31K | $22K |
| Intangible Assets | $0 | $5.9K |
| Other Non-Current Assets | $25K | -- |
| Total Non-Current Assets | $433K | $408K |
| Total Assets | $595K | $666K |
| Accounts Payable | $2.4K | $4.9K |
| Deferred Revenue (Current) | $14K | $0 |
| Total Current Liabilities | $745K | $80K |
| Total Non-Current Liabilities | $107K | $561K |
| Total Liabilities | $852K | $641K |
| Total Debt (incl. Leases) | $198K | $261K |
| Retained Earnings | -$15.97M | -$15.58M |
| Total Stockholders' Equity | -$258K | $26K |
| Total Equity | -$258K | $26K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.14M | $128K | $137K | $79K | $6.3K |
| Cash & Short-Term Investments | $1.14M | $128K | $137K | $79K | $6.3K |
| Accounts Receivable, Net | $53K | $44K | $79K | $33K | $0 |
| Inventory | $348K | -- | -- | $25K | $207K |
| Total Current Assets | $1.56M | $343K | $359K | $162K | $258K |
| Property, Plant & Equipment, Net | $42K | $33K | $35K | $31K | $22K |
| Intangible Assets | -- | -- | -- | $0 | $5.9K |
| Other Non-Current Assets | $30K | -- | -- | $25K | -- |
| Total Non-Current Assets | $889K | $401K | $418K | $433K | $408K |
| Total Assets | $2.45M | $744K | $777K | $595K | $666K |
| Accounts Payable | $23K | $5.2K | $28K | $2.4K | $4.9K |
| Deferred Revenue (Current) | $140K | $64K | $218K | $14K | $0 |
| Total Current Liabilities | $1.44M | $1.06M | $1.11M | $745K | $80K |
| Total Non-Current Liabilities | $47K | $67K | $87K | $107K | $561K |
| Total Liabilities | $1.48M | $1.12M | $1.20M | $852K | $641K |
| Total Debt (incl. Leases) | $139K | $158K | $178K | $198K | $261K |
| Retained Earnings | -$16.25M | -$16.10M | -$16.14M | -$15.97M | -$15.58M |
| Total Stockholders' Equity | $970K | -$477K | -$420K | -$258K | $26K |
| Total Equity | $970K | -$477K | -$420K | -$258K | $26K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 |
|---|---|---|
| Net Income | -$395K | -$181K |
| Depreciation & Amortization | $4.1K | $433 |
| Stock-Based Compensation | $42K | $31K |
| Change in Receivables | -$33K | $0 |
| Change in Payables | -$2.5K | $4.9K |
| Operating Cash Flow | -$179K | -$335K |
| Capital Expenditure | -$13K | -$22K |
| Free Cash Flow | -$192K | -$357K |
| Investing Cash Flow | -$32K | -$26K |
| Common Stock Issued | $70K | $25K |
| Financing Cash Flow | $284K | $367K |
| Net Change in Cash | $73K | $5.8K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$53K | -$56K | -$163K | -$226K | $70K | -$124K | -$116K |
| Depreciation & Amortization | $1.6K | $1.4K | $1.3K | $964 | $1.3K | $1.1K | $774 |
| Stock-Based Compensation | $0 | $0 | $0 | -- | $0 | $0 | $0 |
| Change in Receivables | -$9.5K | $35K | -$46K | $72K | -$103K | -$2.3K | $0 |
| Change in Payables | $188K | -$23K | $26K | -$132 | -$471 | $533 | -$2.4K |
| Operating Cash Flow | -$76K | -$109K | -$55K | -$71K | $59K | -$136K | -$31K |
| Capital Expenditure | -$9.9K | -$1 | -$5.5K | -$1 | $0 | -$13K | $0 |
| Free Cash Flow | -$86K | -$109K | -$61K | -$71K | $59K | -$150K | -$31K |
| Investing Cash Flow | -$9.9K | -$5.3K | -$5.5K | $537 | -$16K | -$14K | -$2.8K |
| Financing Cash Flow | $1.10M | $106K | $118K | -$4.4K | -$4.3K | $228K | $65K |
| Net Change in Cash | $1.01M | -$8.6K | $57K | -$75K | $39K | $78K | $31K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 |
|---|---|---|
| Gross Margin | 27.4% | 34.4% |
| Operating Margin | -52.3% | -2739.0% |
| Net Profit Margin | -56.5% | -2838.0% |
| Return on Equity (ROE) | -- | -709.0% |
| Return on Assets (ROA) | -66.5% | -27.2% |
| Current Ratio | 0.22x | 3.23x |
| Quick Ratio | 0.18x | 0.64x |
| Debt to Equity | -- | 10.22x |
| Revenue Growth (YoY) | +10879.7% | -- |
| Gross Profit Growth (YoY) | +8636.1% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 35.3% | 37.7% | 30.5% | 27.4% | -- | -- | -- |
| Operating Margin | -38.0% | -31.3% | -50.7% | -52.3% | -- | -- | -- |
| Net Profit Margin | -41.5% | -34.8% | -54.9% | -56.5% | -- | -- | -- |
| Return on Equity (ROE) | -51.3% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -20.3% | -50.3% | -56.9% | -66.5% | -- | -- | -- |
| Current Ratio | 1.09x | 0.32x | 0.32x | 0.22x | -- | -- | -- |
| Quick Ratio | 0.85x | 0.16x | 0.19x | 0.18x | -- | -- | -- |
| Debt to Equity | 0.14x | -- | -- | -- | -- | -- | -- |
| Revenue Growth (YoY) | +36.8% | +228.9% | +145.6% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +8.6% | +616.7% | +380.9% | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -149.4% | -- | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -175.3% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -228.0% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -244.9% | -- | -- | -- | -- | -- | -- |